Benicar (olmesartan), a new angiotensin receptor blocker for hypertension
May 2002
Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.
It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).
Reps might tell you that Benicar is more effective...but don't get too excited. It's pretty much a "me-too."
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote